A Cost-Utility Analysis of the Risk Model-Guided Antiemetic Prophylaxis Versus Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Net-Benefit Regression Approach

Saved in:
Bibliographic Details
Published in:Value in health 2016-11, Vol.19 (7), p.A890-A890
Main Authors: Thavorn, K, Vandermeer, L, Mazzarello, S, Wang, Z, Clemons, M
Format: Article
Language:English
Subjects:
Internal Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
DOI:10.1016/j.jval.2016.08.744